Moreover, a common single nucleotide polymorphism (SNP) in human GLI1, which reduces protein activity by around 50%, is associated, in both homozygous and heterozygous states, with increased risk of inflammatory bowel disease (Lees et al., 2008). Here, GLI1 is linked to inflammatory bowel disease.